Clinical trials sponsored by National Cancer Institute, Naples

Phase breakdown

Conditions studied

Recruiting trials led by National Cancer Institute, Naples

• A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)
  NCT04893785 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Effectiveness of Nurse Tele-consultation on the Quality of Elective Colonoscopy, Procedure-related Anxiety, and Financial Toxicity
  NCT06887244 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer
  NCT06509126 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)
  NCT04854213 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)
  NCT07302451 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer
  NCT07213570 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Spatial RadiomIcs and TRanscriptomics to the DIscovery of the Cross-link Between Colon Cancer and ChrOnic Kidney Disease
  NCT06886282 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
  NCT03874026 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
  NCT06714357 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
  NCT05821556 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations

Common questions

How many trials is National Cancer Institute, Naples recruiting for?

National Cancer Institute, Naples is the lead sponsor of 10 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.